Sign in

CIK 0001819576

  • Non-accelerated filer

Liquidia Corp

Sign in to watch
Ticker
LQDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
851710962
Phone
+1 919-328-4400
Business address
419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC, 27560
  1. 4 Planned sale Chief Commercial Officer sold 4,900 shares at $23.41 ($114,709)
  2. 4 Planned sale Chief Medical Officer sold 5,327 shares at $23.41 ($124,705)
  3. 4 Planned sale Chief Accounting Officer sold 1,238 shares at $23.41 ($28,982)
  4. 4 Planned sale Chief Executive Officer sold 20,261 shares at $23.41 ($474,310)
  5. 4 Planned sale Chief Business Officer sold 3,670 shares at $23.41 ($85,915)
  6. 4 Planned sale Chief Human Resource Officer sold 1,691 shares at $23.41 ($39,586)
  7. 4/A Insider Changes in Ownership
  8. 4 Open-market sale Director sold 45,524 shares at $25.81 ($1,174,974)
  9. 4 Open-market sale Director sold 7,500 shares at $29.42 ($220,650)
  10. 4 Planned sale Chief Commercial Officer sold 70,692 shares at an average $28.63 ($2,023,671)
  11. 4 Planned sale General Counsel sold 1,063 shares at $29.05 ($30,880)
  12. 4 Planned sale Chief Human Resource Officer sold 209 shares at $29.05 ($6,071)
  13. 4 Planned sale CFO and COO sold 1,148 shares at $29.05 ($33,349)
  14. 4 Planned sale Chief Accounting Officer sold 296 shares at $29.05 ($8,599)
  15. 4 Open-market sale Director sold 670,837 shares at an average $28.26 ($18,957,475)
  16. 4 Planned sale Chief Business Officer sold 26,508 shares at an average $27.88 ($738,956)
  17. 4 Planned sale Chief Medical Officer sold 20,000 shares at $27.85 ($557,072)
  18. 4 Open-market sale Director sold 5,000 shares at $27.17 ($135,850)
  19. 4 Planned sale CFO and COO sold 20,000 shares at $26.18 ($523,674)
  20. 4 Planned sale CFO and COO sold 30,000 shares at $20.00 ($600,132)

Page 7 of 21 · 410 filings